BDBM741310 US20250161476, P# P17-R

SMILES CCC(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)NCCCCOc1ccc(-c2ccc(C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@](C)(Cc3ccccc3F)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc3nn[nH]n3)NC(=O)C(C)(C)C(=O)NCCc3cnc[nH]3)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCc3cc(C)cc(C)c3)C(N)=O)cc2)c(CC)c1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 741310   

TargetGlucagon-like peptide 1 receptor(Human)
Regeneron Pharmaceuticals

US Patent
LigandPNGBDBM741310(US20250161476, P# P17-R)
Affinity DataEC50:  11.2nMAssay Description:For the assay, HEK293 cells over-expressing full length human GLP-1R were utilized and the downstream cAMP accumulation was assessed as a measure of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent